Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 12 06 2019
accepted: 17 10 2019
pubmed: 9 11 2019
medline: 11 11 2020
entrez: 9 11 2019
Statut: ppublish

Résumé

High dietary salt intake is known to aggravate arterial hypertension. This effect could be of particular relevance in the setting of primary aldosteronism (PA), which is associated with cardiovascular damage independent of blood pressure levels. The aim of this study was to determine the impact of therapy on salt intake in PA patients. A total of 148 consecutive PA patients (66 with unilateral and 82 with bilateral PA) from the database of the German Conn's Registry were included. Salt intake was quantified by 24-hour urinary sodium excretion before and after initiation of PA treatment. Observational longitudinal cohort study. Tertiary care hospital. At baseline, unilateral PA patients had a significantly higher urinary sodium excretion than patients with bilateral disease (205 vs 178 mmol/d, P = 0.047). Higher urinary sodium excretion correlated with an increased cardiovascular risk profile including proteinuria, impaired lipid, and glucose metabolism and was associated with higher daily doses of antihypertensive drugs to achieve blood pressure control. In unilateral disease, urinary sodium excretion dropped spontaneously to 176 mmol/d (P = 0.012) 1 year after unilateral adrenalectomy and remained low at 3 years of follow-up (174 mmol/d). In contrast, treatment with mineralocorticoid receptor antagonists (MRA) in bilateral PA patients was not associated with a significant change in urinary sodium excretion at follow-up (179 mmol/d vs 183 mmol/d). PA patients consuming a high-salt diet, estimated based on urinary sodium excretion, respond to adrenalectomy with a significant reduction of salt intake, in contrast to MRA treatment.

Identifiants

pubmed: 31702016
pii: 5614720
doi: 10.1210/clinem/dgz051
pmc: PMC7010311
pii:
doi:

Substances chimiques

Antihypertensive Agents 0
Biomarkers 0
Sodium Chloride, Dietary 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Endocrine Society 2019.

Références

Lancet. 2001 Mar 17;357(9259):848-51
pubmed: 11265954
Am Heart J. 1984 Nov;108(5):1347-52
pubmed: 6496291
World Health Organ Tech Rep Ser. 2003;916:i-viii, 1-149, backcover
pubmed: 12768890
Am J Physiol Regul Integr Comp Physiol. 2013 Feb;304(3):R252-9
pubmed: 23193117
Lancet. 2009 Mar 7;373(9666):829-35
pubmed: 19223069
J Lab Clin Med. 1992 Dec;120(6):893-901
pubmed: 1453111
BMJ. 2009 Nov 24;339:b4567
pubmed: 19934192
N Engl J Med. 2010 Feb 18;362(7):590-9
pubmed: 20089957
Am J Physiol Regul Integr Comp Physiol. 2013 Jun 15;304(12):R1149-60
pubmed: 23594615
Chest. 2013 Apr;143(4):978-983
pubmed: 23288434
Hypertension. 2004 Jun;43(6):1332-7
pubmed: 15117915
J Hum Hypertens. 2013 Jan;27(1):1-6
pubmed: 22785050
Cochrane Database Syst Rev. 2004;(3):CD004937
pubmed: 15266549
BMJ. 2002 Sep 21;325(7365):628
pubmed: 12242173
Lancet. 2011 Jul 30;378(9789):380-2
pubmed: 21803192
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Hypertension. 2003 Oct;42(4):459-67
pubmed: 12953018
Eur J Endocrinol. 2011 Aug;165(2):301-6
pubmed: 21602315
Hypertens Res. 2002 Sep;25(5):737-42
pubmed: 12452327
J Hum Hypertens. 1989 Oct;3(5):283-8
pubmed: 2810325
J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300
pubmed: 17161262
Nature. 2010 Mar 11;464(7286):297-301
pubmed: 20107438
Hypertension. 2016 Jul;68(1):204-12
pubmed: 27245179
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
Int J Mol Sci. 2017 May 11;18(5):
pubmed: 28492512
Am J Physiol. 1965 Jun;208:1281-5
pubmed: 14301393
Stroke. 2004 Jul;35(7):1543-7
pubmed: 15143292
Hypertension. 2009 Sep;54(3):475-81
pubmed: 19620517
Hypertension. 2006 Aug;48(2):232-8
pubmed: 16801482
BMJ. 2007 Apr 28;334(7599):885-8
pubmed: 17449506
Kidney Int. 2000 Apr;57(4):1337-45
pubmed: 10760064
Eur J Nutr. 2015 Oct;54(7):1109-15
pubmed: 25341396
Pflugers Arch. 2015 Mar;467(3):587-94
pubmed: 25502114
BMJ. 1988 Jul 30;297(6644):319-28
pubmed: 3416162
Hypertension. 2008 Feb;51(2):339-44
pubmed: 18086955
N Engl J Med. 1958 Jun 5;258(23):1152-7 contd
pubmed: 13552935
Neurosci Res. 2016 Jul;108:60-6
pubmed: 26828852
JAMA. 2011 May 4;305(17):1777-85
pubmed: 21540421
J Am Diet Assoc. 2007 Jan;107(1):64-71
pubmed: 17197273
Proc Natl Acad Sci U S A. 1983 Oct;80(19):6136-40
pubmed: 6577473
Hypertension. 2016 Jan;67(1):139-45
pubmed: 26573708
J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8
pubmed: 15837256
Am J Physiol. 1986 Oct;251(4 Pt 2):R762-8
pubmed: 3532826
Hypertension. 2005 Jul;46(1):66-70
pubmed: 15956111

Auteurs

Christian Adolf (C)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Daniel A Heinrich (DA)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Finn Holler (F)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Benjamin Lechner (B)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Nina Nirschl (N)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Lisa Sturm (L)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Veronika Görge (V)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Anna Riester (A)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Tracy A Williams (TA)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.
Divis ion of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.

Marcus Treitl (M)

Klinik und Poliklinik für Radiologie, Klinikum der Universität München, LMU München, Munich, Germany.

Roland Ladurner (R)

Klinik für Viszeral- und Endokrine Chirurgie, Klinikum der Universität München, LMU München, Munich, Germany.

Felix Beuschlein (F)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zurich, Switzerland.

Martin Reincke (M)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Ziemssenstraße, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH